News
Pulmonx
LUNG · NASDAQ
$1.82+$0.07 (+4.00%)TodayMarket closed ·
Prev close $1.75
Latest news
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseGlobe Newswire
Pulmonx Reports Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Pulmonx Reports First Quarter 2026 Financial Results
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
Earnings Summary: Pulmonx Q4
- Press releaseGlobe Newswire
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
- News
Earnings Scheduled For March 4, 2026
- News
Earnings Preview For Pulmonx
- Press releaseGlobe Newswire
Pulmonx Reports Third Quarter 2025 Financial Results
- News
Pulmonx's Earnings: A Preview
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday
- Press releaseBusiness Wire
Calyxo Expands Board of Directors as Number of Patients Treated with its CVAC® System Crosses 20,000 Milestone
- News
A Glimpse Into The Expert Outlook On Pulmonx Through 6 Analysts
- News
Analyst Expectations For Pulmonx's Future
- NewsAvi Kapoor
Crude Oil Falls 1%; Meta Earnings Top Views
- NewsAvi Kapoor
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
Demystifying Pulmonx: Insights From 6 Analyst Reviews
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Top 3 Health Care Stocks You May Want To Dump In February
- Press releaseBusiness Wire
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
- Press releaseGlobe Newswire
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.